logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5137.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5137.produseast1
Conference Material
|Poster

12-month post-treatment outcomes of previously treated drug-resistant tuberculosis patients subsequently treated with concomitant bedaquiline and delamanid +/-carbapenem, in Mumbai, India

Chavan V, Silsarma A, Khan S, Singh P, Iyer A, Mahajan R, Dalal A, Spencer H, Isaakidis P
Download

Similar Content
Video
|Video
12-month post-treatment outcomes of previously treated drug-resistant tuberculosis patients subsequently treated with concomitant bedaquiline and delaminid +/- carbapenem, in Mumbai, India
2024 October 24 • MSF Scientific Days Asia 2024
Loading...
Loading...
12-month post-treatment outcomes of previously treated drug-resistant tuberculosis patients subsequently treated with concomitant bedaquiline and delamanid +/-carbapenem, in Mumbai, India | Conference Material / Poster | MSF Science Portal
No abstract available

Countries

India

Subject Area

tuberculosis

Languages

English
Published Date
08 Nov 2024
Conference
MSF Scientific Days Asia 2024
Linked Content
Conference Material
|Video
12-month post-treatment outcomes of previously treated drug-resistant tuberculosis patients subsequently treated with concomitant bedaquiline and delaminid +/- carbapenem, in Mumbai, India
2024 October 24 • MSF Scientific Days Asia 2024